
Doxonimar Tablet
Marketer
Emcee Pharmaceuticals Pvt Ltd
Salt Composition
Doxofylline (NA)
Overview Doxonimar Tablet
Airolax tablets are prescribed for managing and preventing asthma and chronic obstructive pulmonary disease (COPD) symptoms, conditions characterized by restricted airflow to the lungs. This medication works by relaxing the airway muscles, thereby increasing airflow and easing breathing. Airolax should be taken with food in the evening, adhering strictly to the dosage and duration specified by your physician. The frequency and amount will vary depending on the condition being treated; continue taking the medication for the prescribed period. If you miss a dose, take it as soon as you remember, but remember this medication isn't for immediate relief of acute breathing difficulties; always carry your rescue inhaler. Common side effects include nausea, vomiting, headache, and indigestion. Report any persistent or severe side effects to your doctor; management strategies may be available. During treatment, it's recommended to abstain from alcohol and tobacco. Limit or avoid high-caffeine beverages such as coffee, tea, and dark chocolate due to potential exacerbation of side effects. Before starting treatment, inform your doctor about any kidney, liver, or heart conditions, and disclose all other medications you are currently using, as interactions can affect Airolax's efficacy or mechanism. Disclose your pregnancy or breastfeeding status before commencing treatment.
Uses of Doxonimar Tablet
Managing and mitigating chronic obstructive pulmonary disease (COPD)
Major Benefits of Doxonimar Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Doxonimar Tablet. Ingest the tablet whole; do not crush, chew, or break it. Doxonimar Tablet can be administered with or without food, however, consistent timing is recommended. Refrain from consuming Doxonimar Tablet alongside caffeine or chocolate, including foods and beverages containing them, like tea and cocoa.
Common Side effects of Doxonimar Tablet:
- Headache
- Nausea
- Vomiting
- Upset stomach
How to use Doxonimar Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Doxonimar Tablets. Ingest the tablets whole; do not crush, chew, or break them. Doxonimar Tablets can be taken with or without food, but consistent timing is recommended. To maximize effectiveness, avoid consuming Doxonimar Tablets concurrently with caffeine or chocolate, including foods and beverages containing these substances like tea and cocoa.
How Doxonimar Tablet works:
Doxonimar tablets ease breathing by acting as a bronchodilator. The medication achieves this by relaxing airway muscles, thereby widening the passages for improved airflow.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Doxonimar Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Pregnancy-related data on Doxonimar Tablet use is currently unavailable. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Use of Doxonimar Tablet while breastfeeding is likely unsafe. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Doxonimar Tablets may cause drowsiness, blurred vision, and dizziness, reducing alertness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data on Doxonimar Tablet use in patients with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Doxonimar Tablet's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Doxonimar Tablet :
Should you forget a Doxonimar Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Doxonimar Tablet
| Label | Value |
|---|---|
| Chemical Category | Methylxanthine-based compound |
| Developing Habits | No. |
| Treatment Category | Breathing |
